Skip to main content
Home
  • 服务
    服务

    我们的服务涵盖产品开发和商业化的整个生命周期,既适用于小型本地试验,也适用于大型全球项目。

    Read More
    临床研究服务 商业定位 咨询服务 早期服务 战略性解决方案 语言服务 实验室服务 医学影像服务 真实世界洞察 研究中心及患者解决方案
    clinical-trials-china.jpeg
    COVID-19的临床试验

    Clinical trials during COVID-19.

    clinical-trials-china-2.jpeg
    研究中心和患者

    研究中心和患者识别,入组和参与

  • 治疗领域
    治疗领域

    我们在广泛的治疗领域拥有丰富的经验。我们管理所有主要地区的研究,与世界领先的研究人员建立了稳固的工作关系。

    Read More
    心血管系统 细胞和基因疗法(CGT) 中枢神经系统 内分泌与代谢疾病 感染性疾病 内科与免疫学 医疗器械 肿瘤学 儿科学 罕见病与孤儿病 移植免疫学 女性健康
    icon-china-mega-menu-image.jpeg
    疫苗

    ICON 领导了 18 种疫苗的开发,获得了 FDA/EMA 的批准,其中包括世界上第一个获批的 COVID-19 疫苗

    icon-china-mega-menu-image-2.jpeg
    治疗领域洞察

    ICON 的治疗专家定期为行业出版物内容做出贡献。

  • 加入我们
  • 新闻和活动
  • ICON中国
    ICON中国
    Read More
    ICON中国 公司历史 我们的荣誉 Leadership 联系我们
    esg-mdd.jpg
    环境、社会与公司治理(ESG)

    ICON Cares 代表我们致力于关爱每一个人、环境与社区,并带来积极改变的承诺。

    healthcare-intelligence-video-poster.png
    医疗智能赋能

    推动临床研究不断前行

  • 中国大陆办公室
  • 商务合作
  1. Home
  2. 新闻和活动
  3. 活动一览
  4. Webinars
  5. Developing an Observer-Reported Outcomes Measure (ObsRO)

Developing an Observer-Reported Outcomes Measure (ObsRO)

Learn best practices, challenges, and solutions for using observer-reported outcomes measures in your trial

  • Date 22 June 2016
    Time 11:00 - 12:00
    Location Webinar
    Timezone America/Bogota

    Using a case study approach, webinar participants will learn more about developing ObsROs and implementing them in clinical studies. We’ll discuss some of the key challenges faced in developing and using an ObsRO, along with potential solutions.

On-Demand Webinar Archive

To access the archived recording of this webinar, visit our webinar channel and complete a one time only form. This will give you access to our entire library of archived webinars.

Access Webinar Archive

Overview

While capturing treatment benefit from the patient’s perspective is often important in clinical research, it is not always possible to do so directly through a patient-reported outcomes measure (PRO).

This may be due to the patient’s condition (e.g., severe mental impairment) or because of the patient’s age (e.g., young children). In these cases, an observer-reported outcomes measure (ObsRO) may be used to gain information about the patient from the observations of a caregiver.

Key insights include:

  • What is an ObsRO, and when is it appropriate to use one?
  • What are best practices for developing an ObsRO?
  • What are some of the key challenges in ObsRO development and possible solutions?
  • What are some of the key considerations for implementing an ObsRO in a clinical study?

Featured Speakers

Beverly Romero

MA, Senior Outcomes Researcher, ICON Clinical Outcomes Assessment

Beverly is a senior outcomes researcher in ICON’s, Gaithersburg, Maryland office. She has worked in the field of Clinical Outcomes Assessments (COAs) since 2010, starting with Oxford Outcomes, which was acquired by ICON in 2011. Beverly is an experienced project manager and qualitative researcher with experience in developing ObsROs as well as adult and pediatric PROs.  She has also been involved in large, multinational conjoint, survey, and interview studies. She has worked in a variety of disease areas and populations: pediatric and adult ADHD, pediatric and adult ulcerative colitis, multiple sclerosis, non-small cell lung cancer, type 2 diabetes mellitus, and pediatric and adult CSID. Beverly has a master’s degree in English and a background in teaching and communication.

Emuella Flood

Senior Principal, ICON Clinical Outcomes Assessment

Emuella Flood is a Senior Principal in ICON Clinical Outcomes Assessment (COA) and leads the US East Coast COA team in Gaithersburg, Maryland. She began her career in COA research consulting nearly 20 years ago and has been with the ICON team since 2011. Emuella has directed the development and/or validation of PROs, ObsROs and ClinROs, as well as patient preference, conjoint and satisfaction surveys and patient-reported burden of illness surveys for adult and pediatric populations. She has extensive experience in qualitative research and has presented on best practices at industry conferences, including ISOQOL and ISPOR.  She attends FDA meetings on behalf of sponsors in support of COAs used as key trial endpoints and the basis for labeling.  Emuella is on the editorial board of The Patient, leads the DIA Study Endpoints Educational Series Committee, is co-chair of the ISOQOL Industry Advisory Special Interest Group and is a member of the Patient Preference Methodology working group of the Medical Device Innovation Consortium (MDIC).  She has contributed to over 80 peer-reviewed publications and abstracts.

Target audience

This program is intended for clinical research scientists, study leaders, drug developers, instrument developers, payers and providers.

In this section
In this section
  • In the News
  • Press releases
  • 活动一览
    • Industry events
    • Webinars
    • Workshops
  • DIA China 2022

Connect with us

  • Contact us
  • Submit proposal request
  • Update Email Preferences
  • Global office locator
  • ICON on social media
Site Branding
    ICON plc
  • Contact
  • Results & Reports
For Clients
  • 我们的服务
  • 治疗领域
ICON for
  • 新 闻
  • 加入我们
News & Events
  • 中国大陆办公室
  • 商务合作
Socials
  • WeChat QR code

Legal Footer

  • © 2025 ICON plc
  • Disclaimer
  • Privacy
  • Cookies
How can we help?
  • All
Popular search terms:
  • COVID-19
  • Site & Patient Recruitment
  • Oncology
  • Medical Device
  • Real World Evidence
  • Decentralised & hybrid clinical trials
  • Digital Disruption